Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease

Summary

This is a preliminary, open-label, clinical trial designed to assess the efficacy, safety, and tolerability of vortioxetine for the treatment of major depressive disorder in patients with coronary artery disease. In addition, the study will assess the effects of vortioxetine on heart rate variability in these patients.

Timeline

Start

2016-04

Primary completion

2016-06

Completion

2016-06

Drugs

Indications